Two studies found that using Johnson & Johnson's experimental HIV drug rilpivirine in combination with Gilead Sciences' Truvada worked as well as using Gilead's Atripla or similar medicines alone, with fewer adverse effects. However, 9% of HIV patients failed to respond to the combination treatment, compared with 4.8% of those treated with an older drug.

Full Story:

Related Summaries